Printer Friendly
The Free Library
14,529,525 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Astro-Med to Present at Seventh Annual Needham Growth Conference.


WEST WARWICK, R.I. -- Astro-Med, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ALOT ALOT Allotment
ALOT Adaptive Large Optics Technologies
ALOT Airborne Lightweight Optical Tracking
ALOT Maybe you're looking for the two word phrase 'a lot' meaning many?
) a leading manufacturer of specialty instrument systems and supplies, marketed worldwide under the brand names Astro-Med, QuickLabel Systems and Grass-Telefactor, today announced that Albert W. Ondis, Astro-Med Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will be presenting at the Seventh Annual Needham Growth Conference being held in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 on January 10-14, 2005. The Astro-Med presentation is scheduled for Thursday, January 13 at 9:00 AM EST EST electroshock therapy.

EST
abbr.
electroshock therapy
.

The Needham Growth Conference has become the largest and most prominent emerging growth technology conference in the United States. During the 4-day program, attendance of institutional investors is expected to exceed 1,500.

Following the 30-minute presentation, a 30-minute breakout session will be held. Albert W. Ondis will be joined by Everett V. Pizzuti, President and COO, and Joseph P. O'Connell, Vice President and CFO See Chief Financial Officer. . Astro-Med management will be presenting the company's strategy for sustained growth and increased profitability to a prestigious audience at the New York Palace
  • Palace Theatre, New York
  • New York Palace, Budapest, Hungary
 Hotel in New York City.

The Conference is organized annually by Needham & Company, and participation at the conference is by invitation only. The Needham venue is conducive for a large group presentation, and a smaller, follow-up presentation with one-on-one discussions, providing Astro-Med executives the opportunity to present the company's business plan in depth.

Astro-Med, Inc. is a leading manufacturer of products that are employed around the world for industrial and scientific test and measurement applications, for product identification applications in consumer and industrial markets, and for clinical and research purposes in the field of life sciences.

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2004 annual report and its annual and quarterly filings with the Securities and Exchange Commission.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 13, 2004
Words:302
Previous Article:Magnetek Receives Contract to Develop Subway Car Power Systems.
Next Article:TEL Announces Major Improvements in Plasma Etch Chamber Design That Significantly Improve Throughput and Yield.
Topics:



Related Articles
Astro-Med Reports Third Quarter Results; Directors Declare Regular Cash Dividend.
Astro-Med Forecasts Strong Fourth Quarter; Announces Strategic Alliance.
Astro-Med Reports Second Quarter Results; Directors Declare Regular Cash Dividend.
Astro-Med Reports First Quarter Results; Directors Declare Regular Cash Dividend.
Astro-Med Estimates a Profit for the Fourth Quarter Before Restructuring and Other Non-Cash Charges.
Astro-Med Executes Stock Buy-Back.
Astro-Med Estimates Strong Sales and Profit for the First Quarter.
Astro-Med Reports Strong Second Quarter on Record Sales; Directors Declare Regular Cash Dividend.
Astro-Med Reports Strong Third Quarter on Record Sales; Directors Declare Regular Cash Dividend.
Astro-Med Reports Preliminary Results for Third Quarter.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles